-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Checkpoint Therapeutics, Inc. annual and quarterly Revenues in USD history and change rate from 30 Jun 2022 to 31 Dec 2024.
- Checkpoint Therapeutics, Inc. Revenues for the quarter ending 30 Jun 2024 was $41,000, a 32% increase year-over-year.
- Checkpoint Therapeutics, Inc. annual Revenues for 2024 was $41,000, a 60% decline from 2023.
- Checkpoint Therapeutics, Inc. annual Revenues for 2023 was $103,000, a 46% decline from 2022.